Brammer Bio

Brammer Bio is a Contract Development and Manufacturing Organization (CDMO) that provides services to companies seeking to develop and commercialize cell and gene therapies. With an experienced management team, exceptional scientific expertise, and established manufacturing capabilities, we offer the necessary knowledge and resources to help you deliver innovative cell and gene therapies.Brammer Bio focuses on providing clinical and commercial supply for autologous and allogeneic cell therapies, as well as viral vector products for in vivo and ex vivo therapeutic applications.With process and analytical development alongside regulatory support, we enable large pharmaceutical and biotechnology clients to accelerate the delivery of new drugs and improve patient health.Brammer Bio occupies a 45,000-square-foot facility for process development and Phase I/II clinical manufacturing in Alachua, Florida, and is developing a 50,000-square-foot facility in Lexington, Massachusetts, with plans to construct large-scale Phase III/commercial viral vector manufacturing suites, isolated cell and gene therapy suites, and quality control and analytical laboratories for clinical and commercial launch services.